Investegate |Midatech Pharma PLC Announcements | Midatech Pharma PLC: Proposed Acquisition of Bioasis Technologies Inc
Investegate announcements from Midatech Pharma PLC, Proposed Acquisition of Bioasis Technologies Inc
Stay updated with breaking news from Amendment Agreement. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from Midatech Pharma PLC, Proposed Acquisition of Bioasis Technologies Inc
Toronto, Ontario--(Newsfile Corp. - December 6, 2022) - YANGAROO Inc., (TSXV: YOO) (OTC Pink: YOOIF) ("Yangaroo", "Company"), a software leader in media asset workflow solutions for the advertising and
Investegate announcements from ObsEva SA, ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million
Sale of Ebopiprant royalty and milestone license to XOMA includes upfront payment of $15 million and future milestone payments of up to $98 millionThe sale proceeds are expected to enable ObsEva to resolve
ObsEva SA announced the sale of all of the Company's rights to Ebopiprant to XOMA Corporation for an upfront payment of $15 million and future milestone payments of up to $98 million. ObsEva expects...